Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

ClinicalTrials.gov ID: NCT06817356

Public ClinicalTrials.gov record NCT06817356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Proof of Concept Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this proof-of-concept study to evaluate mazdutide in participants with alcohol use disorder (AUD). For any individual participant, the maximum duration of study participation is approximately 36 weeks, including screening and posttreatment follow-up.

Study identification

NCT ID
NCT06817356
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
308 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 6, 2025 (Actual)
Primary completion
Mar 19, 2026 (Actual)
Completion
May 19, 2026 (Actual)
Last update posted
Jul 16, 2026

2025 – 2026

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Headlands Research - Scottsdale Scottsdale Arizona 85260 —
Woodland Resarch Northwest/ERG Rogers Arkansas 72758 —
Ark Clinical Research - Fountain Valley Fountain Valley California 92708 —
Synergy San Diego Lemon Grove California 91945 —
Headlands Research-Artemis San Diego San Diego California 92123 —
Research Centers of America ( Hollywood ) Hollywood Florida 33024 —
K2 Medical Research - Maitland Maitland Florida 32751 —
K2 Medical Research Maitland Florida 32751 —
Clinical Neuroscience Solutions Inc Orlando Florida 32801 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
K2 Medical Research - Tampa Tampa Florida 33634 —
CenExel iResearch, LLC (CenExel iRA) Decatur Georgia 30030 —
DelRicht Research Mandeville Louisiana 70471 —
Adams Clinical Watertown Massachusetts 02472 —
Vitalix Clinical Worcester Massachusetts 01608 —
Redbird Research LLC Las Vegas Nevada 89119 —
Richmond Behavioral Associates Staten Island New York 10314 —
Ichor Research Syracuse New York 13210 —
Davis Clinical The Bronx New York 10461 —
Summit Headlands Portland Oregon 97210 —
Rhode Island Mood & Memory Research Institute East Providence Rhode Island 02914 —
Medical University of South Carolina Charleston South Carolina 29425 —
Clinical Neuroscience Solutions Inc Memphis Tennessee 38119 —
FutureSearch Trials of Dallas Dallas Texas 75251 —
Dallas Clinical Research Center/Pillar Research Richardson Texas 75080 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06817356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 16, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06817356 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →